StonvexLoading…
StonvexStonvexStonvexCore line items from ALKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $443.64M | $333.85M | $264.83M | $204.27M |
Operating Income | $-53.64M | $-44.63M | $-63.70M | $-57.69M |
Net Income | $-47.65M | $-40.84M | $-62.91M | $-58.60M |
EPS (Diluted) | $-0.46 | $-0.41 | $-0.67 | $-0.64 |
Total Assets | $847.23M | $437.28M | $399.82M | $488.88M |
Total Liabilities | $485.18M | $80.25M | $74.88M | $154.84M |
Cash & Equivalents | $63.46M | $94.36M | $40.93M | $108.72M |
Free Cash Flow OCF − CapEx | $41.36M | $17.40M | $-18.56M | $-39.10M |
Shares Outstanding | 106.10M | 102.09M | 96.72M | 92.11M |